Clinical trial
XLIMus Drug Eluting Stent: a randomIzed Controlled Trial to Assess Endothelization
NCT03745053 is registered in ClinicalTrials.gov with Cardionovum GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- XLIMus Drug Eluting Stent: a randomIzed Controlled Trial to Assess Endothelization
- Lead sponsor
- Cardionovum GmbH
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 5, 2019
- Completion date
- September 2, 2023
- Enrollment
- 180 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.